Clearside Biomedical Inc (CLSD)
1.35
-0.14
(-9.40%)
USD |
NASDAQ |
May 22, 16:00
1.35
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.345M |
| September 30, 2023 | 0.717M |
| June 30, 2023 | 0.805M |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.126M |
| September 30, 2022 | 0.266M |
| June 30, 2022 | 0.384M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.126M
Minimum
Dec 2022
6.345M
Maximum
Dec 2023
1.440M
Average
0.5505M
Median
Gross Profit (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| Heron Therapeutics Inc | 26.23M |
| Actinium Pharmaceuticals Inc | -- |
| Karyopharm Therapeutics Inc | 31.22M |
| Ocular Therapeutix Inc | 13.45M |